Effect of Rosuvastatin on Cytokines After Traumatic Brain Injury

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 31, 2009

Primary Completion Date

July 31, 2011

Study Completion Date

August 31, 2011

Conditions
Head Injury
Interventions
DRUG

Rosuvastatin

20 mg oral, for 10 days

DRUG

Placebo

20 mg vehicle

Trial Locations (1)

78420

"Hospital Central Dr. Ignacio Morones Prieto", San Luis Potosí City

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

"Hospital Central Dr. Ignacio Morones Prieto"

OTHER

collaborator

AstraZeneca

INDUSTRY

lead

Universidad Autonoma de San Luis Potosí

OTHER